Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
JanOne has received confirmation from the FDA for the IND sponsorship transfer covering its sodium nitrite tablets previously held by Soin Neuroscience.
read more
Moderna has announced that the Phase 3 study of its mRNA vaccine candidate (mRNA-1273) against COVID-19 has begun dosing participants.
read more
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma.
read more
Novavax and FUJIFILM Diosynth Biotechnologies has announced an agreement to manufacture bulk drug substance for NVX-CoV2373, Novavax' COVID-19 vaccine candidate.
read more
Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 50 mL vial.
read more
MediciNova announced an agreement with BioComo and Mie University for joint development of a SARS-CoV-2 vaccine using BC-PIV, a human parainfluenza virus type 2 vector.
read more
Bora has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Arctoris has established a broad range of remotely accessible COVID-19 assays.
read more
Catalent plans to invest $30 million at its facility in Limoges, France, to create a European center of excellence for clinical biologics formulation development and drug product fill-finish services.
read more
Sorrel Medical has entered into a strategic partnership with pharmaceutical companies to advance the development and introduction of next-generation wearable drug delivery solutions.
read more
Catalent will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s anti-human GM-CSF monoclonal antibody.
read more
SCA Pharma plans to expand its sterile pharmaceutical manufacturing facility in Windsor by 40 percent.
read more
Lantern Pharma announced agreements with contract manufacturing companies for process development and manufacturing for two of Lantern's oncology drug candidates, LP-300 and LP-184.
read more
The company is now supporting more than 200 of these projects globally.
read more
Cobra has successfully produced and supplied two further DNA plasmids for the production of CombiGene’s gene therapy drug candidate CG01.
read more